Sanofi (SNY) Receivables - Net (2009 - 2026)

Sanofi (SNY) has 18 years of Receivables - Net data on file, last reported at $27.5 billion in Q1 2026.

• Quarterly Receivables - Net rose 19.72% year-over-year to $27.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.5 billion (up 19.72% YoY) and the FY2025 annual result came in at $26.4 billion, up 221.96% from the prior year.
• Receivables - Net advanced to $27.5 billion in Q1 2026 per SNY's latest filing, from $26.4 billion in the prior quarter.
• The five-year high for Receivables - Net was $28.6 billion in Q3 2025, with the low at $8.2 billion in Q4 2024.
• Average Receivables - Net over 5 years is $15.2 billion, with a median of $9.1 billion recorded in 2023.
• Year-over-year, Receivables - Net declined 9.59% in 2024 and jumped 221.96% in 2025.
• Sanofi's Receivables - Net stood at $8.6 billion in 2022, then increased by 5.57% to $9.1 billion in 2023, then retreated by 9.59% to $8.2 billion in 2024, then jumped by 221.96% to $26.4 billion in 2025, then advanced by 4.18% to $27.5 billion in 2026.
• Business Quant data shows SNY's Receivables - Net at $27.5 billion in Q1 2026, $26.4 billion in Q4 2025, and $28.6 billion in Q3 2025.